A new study from researchers at UTHealth Houston suggests that a high-dose influenza vaccine may offer older adults significantly greater protection against Alzheimer's disease than the standard formulation. The analysis, which examined nearly 200,000 adults aged 65 and older, found that participants who received the high-dose flu shot had a nearly 55 percent lower risk of developing Alzheimer's disease. That figure compares with the roughly 40 percent reduction previously associated with the standard-dose vaccine, according to the researchers behind the findings.
The results add to a growing body of evidence linking influenza vaccination to reduced Alzheimer's risk, though the observational nature of the study means it cannot establish direct causation. Scientists have not yet determined the biological mechanisms that might explain the association, and further research is needed to confirm whether the stronger vaccine itself confers the additional protection or whether other factors among recipients play a role. The findings nonetheless carry potential implications for vaccination guidance for older adults, a population at elevated risk for both severe influenza and Alzheimer's disease.
Independent reporting synthesized from primary wires and global correspondents.